Special Research Program SFB-54: "InThro"


Thrombosis is a hallmark of life-threatening diseases, such as myocardial infarction, stroke or venous thromboembolism representing major causes of death in the western civilization. In 2014 the Special Research Program SFB-F54 (“Cellular Mediators Linking Inflammation and Thrombosis”) was launched at the Medical University Vienna financed by the Austrian Science Fund (FWF), which comprises a network of eight research groups that are focusing on molecular and cellular links between inflammation and thrombotic diseases to provide a new view of thrombosis integrating the role of inflammatory processes thereby building up new strategies for therapeutic interventions.

Our Special Research Program SFB-F54 has been extended for a second funding phase from 2018 - 2022.



“From lipids to thrombosis: translational research targeting HDL and platelet function”


News and recent publications


Thrombotic occlusion of blood vessels, which leads to myocardial infarctions, strokes and venous thromboembolisms, is the major cause of death in the western hemisphere. Therefore, it is of critical importance to understand mechanisms preventing..


Covid-19-Patienten leiden nicht nur direkt unter dem Virus. Sie sind auch von zahlreichen Begleiterkrankungen betroffen. So haben Wiener Forscher nun den Zusammenhang mit Beinvenenthrombose bzw. Lungenembolie nachgewiesen. In einer..


“Ikk2-mediated inflammatory activation of arterial endothelial cells promotes the development and progression of atherosclerosis”


Single-cell Sequencing of Epigenetic Disease Landscapes and Induced Perturbations